Promoting and protecting the health and safety of all Idahoans
Español    About Us    Contact Us    Careers   
November 12, 2018

Respiratory Syncytial Virus (RSV)

In Idaho, Respiratory Syncytial Virus (RSV) surveillance efforts are planned to begin the week ending November 10, 2018.

Infants and children at risk for severe RSV infection can receive monthly doses of palivizumab (Synagis™) as prophylaxis during the RSV season. Voluntary RSV surveillance is conducted to inform healthcare providers about RSV trends in Idaho that may impact prescribing recommendations for palivizumab (Synagis™).

The beginning of the RSV season, or season onset, is adapted from the National Respiratory and Enteric Virus Surveillance System (NREVSS). RSV season onset occurs in the first of two consecutive weeks during which the reported total percentage of specimens testing positive for antigen is ≥10%. 

 2018-2019 Weekly RSV Season Data - Idaho  - COMING SOON

Public Health District 1 2 3 & 4 5 6 7 IDAHO
Total Positive Tests* 

 Total Tests Submitted
 Percent Positive                                        
 *For week ending:            

Updated November 1, 2018